Ami Lifesciences, backed by Private equity firm Kedaara, appoints Amit Kaptain as CEO.
Amit brings 20+ years of experience in the API industry. He has worked with large Indian MNCs, such as Dr Reddy’s, Ranbaxy and Sun Pharma, in global sales, marketing and operations.
Before joining Ami Lifesciences, Amit worked as COO at Aurore Lifesciences.
As CEO, Amit is responsible for building business strategy and longstanding global partnerships with leading pharmaceutical companies (including big pharma and innovators) by developing products in niche therapeutic areas and becoming a reliable partner of choice from India.
The Gujarat-based pharma company Ami Lifesciences was started in 2004 by Girish Chovatia, CMD of Ami Lifesciences. The company has a market presence in 44 countries and is one of the leading manufacturers and exporters of API’s and advanced pharmaceutical intermediates to leading Pharmaceutical companies of the world, according to the company website.